bims-moremu Biomed News
on Molecular regulators of muscle mass
Issue of 2026–11–22
39 papers selected by
Anna Vainshtein, Craft Science Inc.



  1. Am J Physiol Cell Physiol. 2026 Nov 18.
      Wedged between the sarcolemma and basal lamina, satellite cells (SCs) are resident skeletal muscle stem cells responsible for regeneration following injury. SCs share this microenvironment with fibrogenic, immune, vascular, and neural cell populations. Accumulating evidence indicate that SCs do more from this position than regenerate muscle. Activated SCs participate directly in extracellular matrix (ECM) remodeling and signal to fibroblasts and fibro-adipogenic progenitors (FAPs) through miRNA-containing extracellular vesicles (EVs). SCs also reside near capillaries, where reciprocal signaling with endothelial cells stimulates angiogenesis and in return influences myofiber adaptation. SCs are also localized at the neuromuscular junction (NMJ), where they secrete proteins implicated in synaptic remodeling. During regeneration, SCs share their environment with infiltrating immune cells, and while the influence of macrophages on SCs is well established, the reciprocal direction remains comparatively unexplored. EV transport has emerged as one candidate mechanism for part of this influence, operating independently of SC-myofiber fusion. However, supporting evidence is stronger for fibroblasts and FAPs than for endothelial cells and is currently absent for NMJ, immune cells, and non-myogenic fate transitions. The consequences of losing SCs are evident in SC depletion models, where muscle develops excess collagen, blunted capillary expansion, and NMJs that regenerate poorly and degenerate prematurely with age. Whether SCs also transition to fibrogenic or adipogenic fates in aged and dystrophic muscle remains less clear. This review highlights non-canonical roles of SCs and evaluates fusion-independent communication, including SC-derived EVs, as a candidate mechanism linking SCs to the fibrogenic, immune, vascular, and neural compartments of muscle.
    Keywords:  FAPs; extracellular matrix remodeling; extracellular vesicles; muscle regeneration; neuromuscular junction; skeletal muscle hypertrophy; vascular crosstalk
    DOI:  https://doi.org/10.1152/ajpcell.90104.2026
  2. Skelet Muscle. 2026 Aug 25. pii: 43. [Epub ahead of print]16(1):
       BACKGROUND: Eccentric contraction (ECC)-induced force loss is one of the most robust and reproducible phenotypes of the dystrophin-deficient mdx mouse, which is the most widely studied model of Duchenne muscular dystrophy. Despite its utility as a quantitative assessment of therapeutic efficacy in preclinical trials, the mechanism of ECC force loss in mdx skeletal muscle remains incompletely understood. We have previously shown that dystrophin directly interacts with non-muscle cytoplasmic actin isoforms in structures called "costameres" and that oxidative stress and altered redox metabolism contribute to ECC force loss in mdx muscle.
    METHODS: Key methods include physiological measurement of skeletal muscle isometric and eccentric force (in vitro) and torque (in vivo), DCF fluorescence, and histopathological and biochemical assessment of skeletal muscle.
    RESULTS: Here we demonstrate that extensor digitorum longus (EDL) muscles from muscle-specific, cytoplasmic β-actin knockout (ms-Actb KO) mice also present with significant ECC force loss, but the phenotype progresses more slowly and is of lower magnitude compared to mdx EDL muscles. We further demonstrate that muscle-specific transgenic overexpression of cytoplasmic β-actin protects ms-Actb KO muscles from ECC force loss. Consistent with our previous results in mdx mice, treatment of ms-Actb KO EDL muscles with the redox modulators N-acetylcysteine or the H2S donor sodium hydrogen sulfide prevents ECC force loss to a similar extent as transgenic cytoplasmic β-actin replacement. Different from mdx, however, ms-Actb KO ECC force loss occurs in the absence of a concomitant increase in ECC-induced reactive oxygen species production.
    CONCLUSIONS: Our results implicate oxidative stress and altered redox metabolism as critical regulators of ECC force loss in two independent models of myopathy. Together, the data presented here enhance the understanding of ECC force loss in both dystrophin-deficient and cytoplasmic β-actin-deficient forms of myopathy, specifically expanding on a unifying, redox-based mechanism of ECC force loss to include a non-dystrophin-deficient model of myopathy.
    Keywords:   Mdx ; Cytoplasmic actin; Duchenne muscular dystrophy; Eccentric contraction; Hydrogen sulfide; Muscle physiology; NAC; Redox signaling; Skeletal muscle
    DOI:  https://doi.org/10.1186/s13395-026-00443-4
  3. Mol Med. 2026 Nov 17. pii: 228. [Epub ahead of print]32(1):
       BACKGROUND: Cerebral palsy (CP) is associated with progressive skeletal muscle weakness and reduced physical capacity, yet the contribution of mitochondrial dysfunction to these impairments remains incompletely understood.
    METHODS: We therefore evaluated skeletal muscle mitochondrial health in children with CP and typically developing (TD) children (12.9±3.4years) using a comprehensive approach integrating high-resolution respirometry, targeted protein analyses, circulating biomarkers, and plasma proteomics. Thirty-six skeletal muscle biopsies from 22 children with CP, and 15 muscle biopsies from TD children were collected during planned orthopedic surgery.
    RESULTS: Skeletal muscle from children with CP exhibited markedly reduced oxidative capacity (-50% in CP vs TD, p<0.001), accompanied by broad reductions in mitochondrial and substrate transport proteins suggesting reduced mitochondrial content. Despite the absence of local or systemic inflammation, circulating growth differentiation factor-15 (GDF-15), a biomarker of mitochondrial distress, was elevated in children with CP (337±53 vs 626±547pg·ml-1 for TD vs CP, p<0.05) and was highest among those with more severe motor impairments.
    CONCLUSION: These findings demonstrate that previously reported reductions in skeletal muscle mitochondrial protein content in CP translate into profound impairments in mitochondrial function. Moreover, the dissociation between mitochondrial dysfunction and inflammatory signaling suggests that mitochondrial insufficiency in CP occurs independently of inflammation. Elevated circulating GDF-15 further suggests that mitochondrial dysfunction in CP may extend beyond skeletal muscle and exert systemic effects. Together, our findings identify mitochondrial insufficiency as a prominent feature of skeletal muscle pathology in CP potentially acting as a contributor to secondary health complications across the lifespan.
    Keywords:  Cerebral palsy; ELISA; GDF-15; Mitochondria; Muscle fibers; OXPHOS; Olink; Respiration; Western blot
    DOI:  https://doi.org/10.1186/s10020-026-01700-4
  4. Diabetes. 2026 Nov 19. pii: db260508. [Epub ahead of print]
      Mitochondrial fission, mediated in part by dynamin-related protein 1 (DRP1), is a critical modulator of mitochondrial quality control and skeletal muscle function. We investigated the effects of reduced DRP1 action in muscle cells on mitochondrial morphology and local and systemic metabolism in adult mice. DRP1 downregulation in vitro resulted in elongated mitochondria, decreased mitochondria and endoplasmic reticulum contacts, and induced stress-response pathways. In contrast, selective DRP1 deletion in adult skeletal muscle using a tamoxifen-inducible Cre-loxP system (knockout [KO]) did not alter mitochondrial morphology or respiratory capacity. Nonetheless, KO mice exhibited markedly reduced age- and diet-dependent weight gain and adiposity, in concert with increased energy expenditure, compared with littermate controls. KO mice had enhanced insulin sensitivity, suppressed hepatic glucose production, and elevated glucose uptake in skeletal muscle and thermogenic adipose tissue. Mechanistically, transcriptomic profiling identified induction of activating transcription factor 4, and its downstream targets, fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) in skeletal muscle, which correlated with elevated circulating levels. In conclusion, DRP1 downregulation in adult skeletal muscle prevents obesity, increases insulin sensitivity, and improves glucose disposal, likely via activation of adaptive stress pathways and induction of FGF21 and GDF15 as myokines in the absence of changes in mitochondrial morphology or bioenergetics.
    ARTICLE HIGHLIGHTS: Reduced mitochondrial fission has been implicated in metabolic regulation, but the role of DRP1 in adult skeletal muscle metabolism remains incompletely understood. We investigated whether skeletal muscle-specific DRP1 deficiency in adult mice alters mitochondrial morphology and function and influences whole-body energy and glucose metabolism. Adult skeletal muscle DRP1 deficiency prevented age- and diet-induced obesity, increased energy expenditure, improved insulin sensitivity and glucose disposal, and induced ATF4-dependent stress responses with increased FGF21 and GDF15 production despite preserved mitochondrial morphology and respiratory capacity. These findings identify DRP1 as a regulator of systemic metabolic homeostasis and suggest that muscle stress signaling can improve metabolic health independently of changes in mitochondrial morphology.
    DOI:  https://doi.org/10.2337/db26-0508
  5. Am J Physiol Cell Physiol. 2026 Nov 17.
      Metformin, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) and sodium glucose cotransport 2 inhibitors (SGLT2i) are the most frequently prescribed medications for the treatment of diabetes. While the efficacy of these anti-diabetic drugs is clear, the underlying mechanisms of how they improve metabolism and produce other seemingly beneficial off-target effects are not clear. Several tissues including skeletal muscle have been implicated in the on-target and off-target actions of these drugs. Satellite cells are muscle stem cells that are important for skeletal muscle adaptation to stimuli such as exercise. In this mini-review, we present the emerging evidence exploring whether Metformin, GLP-1RA, SGLT2i modulate satellite cell function and if this is a relevant therapeutic target.
    Keywords:  GLP-1; Metabolism; Metformin; Muscle Health; Muscle Stem Cells; Pharmacological Agents; Repurposing; SGLT2i
    DOI:  https://doi.org/10.1152/ajpcell.90171.2026
  6. Skelet Muscle. 2026 Aug 24. pii: 42. [Epub ahead of print]16(1):
      N6-methyladenosine (m6A) is a highly conserved posttranscriptional modification essential for gene expression, cellular function, and the determination of stem cell fates. As a result, it is regulated by a variety of mechanisms and remains a promising field of study. m6A RNA methylation is mediated by multiple classes of proteins, known as writers, erasers, and readers, which are in turn controlled by various transcription factors and regulatory pathways. Dysregulation of these fundamental processes is implicated in a wide range of diseases and disorders, exemplifying their importance in guiding normal physiological activity. In this review, we focused on the effects of m6A modification on muscle stem cells (MuSCs), also known as satellite cells, a critical component of skeletal muscle development and regeneration. Further, we evaluated the contemporary literature and expert perspectives to outline the mechanisms of m6A RNA methylation, emphasizing their roles in MuSCs and their potential for developing novel therapeutic strategies.
    DOI:  https://doi.org/10.1186/s13395-026-00442-5
  7. Mol Metab. 2026 Nov 14. pii: S2212-8778(26)00158-4. [Epub ahead of print] 102474
      Human skeletal muscle is the principal site of insulin-stimulated glucose disposal and a major mediator of exercise-induced metabolic benefits, yet human models that preserve metabolic and exercise responsiveness remain limited. We generated primary human skeletal muscle organoids from donor-derived CD56+ myoblasts using a collagen-based extracellular matrix and serum-free IGF1-guided differentiation. The organoids formed aligned contractile tissues containing oxidative and glycolytic fiber type-like myotubes, displayed enhanced mitochondrial respiration, insulin-stimulated glucose uptake, and reproducible force generation. Electrical pulse stimulation induced AMPK activation, increased glucose utilization and lactate production, and upregulated canonical exercise-responsive genes including NR4A3 and PPARGC1A. Notably, transcriptional responses to in vitro exercise overlapped with acute exercise responses observed in skeletal muscle biopsies from the same donors. The organoids further detected functional impairments of skeletal muscle performance induced by TGF-β1 and metformin and increased speed generation by testosterone treatment. These findings establish a donor-derived human skeletal muscle platform that recapitulates key features of insulin action and exercise adaptation and may enable mechanistic studies of skeletal muscle metabolism, exercise responsiveness, and therapeutic interventions relevant to diabetes.
    Keywords:  Diabetes; Exercise; Human skeletal muscle organoids; Insulin; Metformin; TGFbeta; Testosterone
    DOI:  https://doi.org/10.1016/j.molmet.2026.102474
  8. Adv Funct Mater. 2026 Oct 22. 36(85): e78165
      Lipid nanoparticles (LNPs) have emerged as powerful vehicles for mRNA therapeutics, yet efficient delivery to skeletal muscle remains challenging. Here, we engineer LNPs by integrating Myomaker, a muscle-specific fusogen, onto their surface to enhance skeletal muscle delivery. Optimized Myomaker-LNP (Mymk-LNP) formulations demonstrated high fusogen integration, uniform size, and efficient mRNA encapsulation. Mymk-LNPs exhibited selective in vitro transfection in differentiating myocytes while minimizing uptake in myoblasts and fibroblasts. Systemic and local administration of Mymk-LNPs in vivo led to significantly increased mRNA delivery to skeletal muscle, particularly in models with muscles undergoing fusion, such as developing muscles in neonatal mice and chemically injured muscles in adult mice. Furthermore, Mymk-LNPs mediated efficient Cre mRNA-mediated DNA recombination in injured skeletal muscle as quantified by activation of a Cre-dependent tdTomato reporter. These findings highlight the potential of fusogen-engineered LNPs as a targeted and effective platform for delivery of mRNA therapeutics to muscle.
    Keywords:  cell biology; gene delivery; lipid based nanoparticles; messenger rna; skeletal muscle; transfection
    DOI:  https://doi.org/10.1002/adfm.78165
  9. Geroscience. 2026 Nov 19.
      Mitochondria-endoplasmic reticulum contact sites (MERCs) are critical structural hubs that integrate cellular signaling, bioenergetics and proteostasis. In skeletal muscle, a tissue exceptionally vulnerable to age-related decline, MERCs physically and functionally link mitochondria with the sarcoplasmic reticulum (SR), with mitochondria to govern excitation-contraction coupling, coordinating calcium (Ca2+) homeostasis and metabolic homeostasis. While Sarcopenia (age-related muscle loss) and anabolic resistance-the blunted hypertrophic response to nutrition or contractile stimuli, have traditionally been attributed to factors such as mitochondrial dysfunction, hormonal shifts, and chronic low-grade inflammation, growing evidence positions MERCs as a spatial nexus where these pathogenic processes converge. This review examines fundamental biology of muscle MERCs, detailing their specialized molecular architecture, tethering complexes, and physiological roles in Ca2+ dynamics, bioenergetics, and proteostasis. We then evaluate how aging perturbs MERC ultrastructure characterized by the loss of structural tethers and progressive widening of SR-mitochondrial gaps and discuss how these changes are not merely correlative but are potentially mechanistically linked to impaired anabolic signaling. Specifically, we synthesize structural and molecular evidence illustrating how age-associated contact deterioration uncouples excitation-metabolism signaling, tipping myofibers into local energetic shortfalls and blunting translational control. Furthermore, we connect this loss of organellar coordination to quantifiable functional deficits, including slowed relaxation kinetics, impaired metabolic flexibility, and suppressed hypertrophic responsiveness. Finally, we explore potential emerging countermeasures aimed at stabilizing ER-mitochondrial coupling, spanning exercise, dietary compounds, and pharmacological stabilizers alongside translational perspectives across species, muscle types. Collectively, muscle MERCs emerge as a unifying mechanistic node in sarcopenia, linking nanoscale architecture to cellular energetic, anabolic resistance, and muscle longevity.
    Keywords:  Aging; MAM; MERC; Sarcopenia; Skeletal muscle
    DOI:  https://doi.org/10.1007/s11357-026-02653-6
  10. Curr Opin Cell Biol. 2026 Nov 16. pii: S0955-0674(26)00089-X. [Epub ahead of print]104 102701
      The regenerative capacity of satellite cells sustains skeletal muscle growth and repair but is greatly reduced in advanced ages, compromising muscle function. This age-associated decline reflects both disrupted intrinsic programs that normally ensure the fidelity of cell state transitions, and dysregulated signalling cues from the niche and systemic environment. Recent work has now built an integrative framework of satellite cell aging, in which bidirectional communication between satellite cells and their niche amplifies functional decline. Here, we discuss novel findings on the intrinsic mechanisms of satellite cell aging, which integrate proteostatic failure, metabolic rewiring, and epigenetic (de)regulation into a central underlying axis. At the extrinsic level, we highlight emerging communication networks involving multiple niche compartments and interorgan communication axes linking systemic physiology to satellite cell aging. Finally, we discuss new directions guiding therapeutic interventions aimed at restoring satellite cell function in aged muscle.
    DOI:  https://doi.org/10.1016/j.ceb.2026.102701
  11. Front Physiol. 2026 ;17 1885709
      Skeletal muscle regeneration is a highly coordinated process that depends on muscle satellite cells (MuSCs) and is intricately regulated by metabolic and epigenetic mechanisms. Exercise, recognized as a vital non-pharmaceutical intervention, can significantly enhance the regenerative capacity of skeletal muscle; however, the underlying molecular mechanisms remain inadequately understood. Recent studies suggest that the metabolic products generated during exercise are not merely by-products of energy metabolism; rather, they act as essential regulatory factors involved in epigenetic reprogramming. These metabolites, which include lactate, α-ketoglutarate (α-KG), acetyl-CoA, nicotinamide adenine dinucleotide (NAD+), and S-adenosylmethionine (SAM), serve as substrates, cofactors, or signaling molecules. They directly influence the activities of epigenetic enzymes such as histone acetyltransferases, deacetylases, demethylases, and DNA methyltransferases. This mechanism converts dynamic changes in metabolic states into stable chromatin modifications and gene expression programs, thereby affecting the activation, proliferation, and differentiation of MuSCs. This article presents a systematic review of the regulatory mechanisms that govern the metabolic-epigenetic axis during skeletal muscle regeneration. It emphasizes the role of exercise-induced metabolites in facilitating cell reprogramming through chromatin remodeling. Additionally, the article proposes an integrated theoretical framework that underscores the dynamic coordination of metabolic signals and their time-dependent characteristics throughout various stages of regeneration. Furthermore, it explores potential clinical translational strategies aimed at targeting metabolic-epigenetic coupling, including personalized exercise interventions and metabolic supplementation regimens. A comprehensive understanding of this regulatory network is expected to provide a new theoretical foundation for the precise treatment of muscle injuries, age-related sarcopenia, and metabolic diseases.
    Keywords:  epigenetic enzymes; exercise intervention; metabolites; muscle satellite cells; sarcopenia; skeletal muscle regeneration
    DOI:  https://doi.org/10.3389/fphys.2026.1885709
  12. Placenta. 2026 Nov 15. pii: S0143-4004(26)00748-4. [Epub ahead of print]186 342-345
      Placental mechanisms driving the decline in maternal insulin sensitivity during pregnancy remain poorly understood. We examined the influence of microRNAs from the placental chromosome 19 microRNA cluster (C19MC) on insulin pathway activation in primary human skeletal muscle cells. Mimics of miR-517a-3p and miR-524-5p reduced insulin-stimulated insulin receptor- β phosphorylation, IRS-1 protein levels, and GLUT4 translocation to the cell membrane. These results suggest that placental C19MC microRNAs impair insulin signaling in skeletal muscle and point to a mechanism linking placental microRNA release to reduction of maternal insulin sensitivity in pregnancy.
    Keywords:  C19MC; GLUT4; Glucose uptake; Insulin pathway; Muscles; microRNA
    DOI:  https://doi.org/10.1016/j.placenta.2026.11.012
  13. Stem Cell Res Ther. 2026 Aug 26. pii: 437. [Epub ahead of print]17(1):
       BACKGROUND: Sarcopenia, an age-related skeletal muscle disorder, is characterized by progressive loss of muscle mass, strength, and function. Exercise and nutritional interventions are integral to management, but mechanism-based therapies are limited. Chronic low-grade inflammation and remodeling of the immune microenvironment may impair muscle maintenance and regeneration.
    MAIN BODY: We synthesize findings on immune dysregulation in sarcopenia, focusing on macrophage interactions with muscle stem cells and fibro-adipogenic progenitors. We also examine alterations in T cells, neutrophils, B cells, and natural killer cells from the perspective of aging. We link DNA damage-related inflammation, epigenetic alterations, and metabolic disturbances within an immune-metabolic-regenerative framework. We also assess mesenchymal stem cell (MSC)-mediated regulation through paracrine signaling, extracellular vesicles, cell-cell contact, and mitochondrial transfer. Since much of this evidence derives from inflammation or injury models and immune-cell studies, its linkage to primary sarcopenia remains incompletely validated.
    CONCLUSION: MSCs and MSC-derived extracellular vesicles represent promising but investigational approaches for targeting the aged muscle immune-metabolic niche. By distinguishing mechanisms supported by sarcopenia or aged-muscle evidence from those that remain extrapolative or hypothesis-generating, this review provides an evidence-stratified framework to guide future mechanistic studies and therapeutic development.
    Keywords:  Immune metabolism; Immune regulation; Mesenchymal stem cells; Mitochondrial transfer; Sarcopenia
    DOI:  https://doi.org/10.1186/s13287-026-05278-w
  14. bioRxiv. 2026 Nov 13. pii: 2026.11.11.766063. [Epub ahead of print]
       Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, have transformed the pharmacological treatment of obesity. While highly efficacious in promoting weight loss, these drugs also induce substantial reductions in lean mass, raising concerns for skeletal muscle loss, particularly in older individuals vulnerable to sarcopenia. Nevertheless, there are currently no published human studies that investigated the effects of GLP-1RAs on skeletal muscle mass using gold standard methods. Meanwhile, studies in young mice demonstrate that skeletal muscle loss induced by GLP-1RAs might not be a major concern. The purpose of the current study was to investigate the effects of semaglutide on skeletal muscle mass and strength in aged mice.
    Methods: Eighteen-month-old male and female C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to induce obesity. At 21 months of age, mice received daily subcutaneous injections of vehicle or semaglutide (3 or 30 nmol/kg) for 3 weeks. Body composition was assessed weekly by nuclear magnetic resonance (NMR) spectroscopy. After 3 wks, mice were terminated to assess masses of individual organs including skeletal muscle. Skeletal muscle force-generating capacity was assessed by ex vivo electrical stimulation-induced contraction. Myofiber cross-sectional area and fiber-type composition were also assessed.
    Results: Semaglutide induced dose-dependent weight loss in both sexes, with reductions of 11.3% and 20.2% in males and 21.1% and 26.1% in females receiving 3 or 30 nmol/kg dose, respectively. There was a substantial sex-difference in the loss of lean mass, with relatively minor reductions in males (2.3% and 6.6%) and greater loss in females (8.6% and 8.3%). Skeletal muscle mass was largely preserved in males but females exhibited greater muscle mass loss, including 14.2% reduction in quadriceps mass at 30 nmol/kg of semaglutide treatment. In contrast, skeletal muscle force-generating capacity was not compromised in semaglutide-treated females, while males exhibited 19.2% reduction in force generating capacity of the extensor digitorum longus (EDL) muscles at the 30 nmol/kg dose.
    Conclusion: Unlike young mice, semaglutide treatment may induce meaningful loss in skeletal muscle mass in aged female mice and muscle strength in aged male mice. These findings highlight the importance of considering age as a potential factor that may negatively influence muscle mass and function in humans treated with GLP-1RAs. Clinical studies examining the influence of pharmacological weight loss on skeletal muscle mass and strength should consider both age and sex as a potentially important determinant of these outcomes.
    DOI:  https://doi.org/10.64898/2026.11.11.766063
  15. Bone Res. 2026 Nov 20. pii: 110. [Epub ahead of print]14(1):
      Improving skeletal muscle strength and mass is an essential strategy to prevent and treat sarcopenia, which can be achieved by increasing the number of muscle fibers. Here, we report that phospholipase C-γ1 (PLC-γ1), a member of phospholipase C family that functions as signal transducer by hydrolyzing membrane lipids to generate second messengers, was highly expressed in skeletal muscle fibers. PLC-γ1 expression in the skeletal muscle of elderly individuals was significantly lower than that in young individuals. Conditional knockout of PLC-γ1 in the skeletal muscle in mice showed decreases in the expression of peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α), mitochondrial oxidative phosphorylation, number of slow-twitch skeletal muscle fibers, and exercise endurance. Overexpression of PGC-1α rescued decreases in mitochondrial oxidative phosphorylation, number of slow-twitch skeletal muscle fibers, and exercise endurance induced by conditional knockout of PLC-γ1 in the skeletal muscle. These findings suggest that PLC-γ1 is required for maintaining slow-twitch fiber content and exercise endurance in mice, and that it exerts these effects by sustaining PGC-1α expression.
    DOI:  https://doi.org/10.1038/s41413-026-00593-7
  16. Exp Physiol. 2026 Nov 14.
      Reactive oxygen species are essential signalling molecules that regulate numerous aspects of skeletal muscle physiology. These effects are mediated through redox post-translational modifications on protein cysteine thiols, which influence the structure and function of redox-sensitive proteins. Mass spectrometry-based redox proteomic approaches have greatly advanced our ability to detect and characterise cysteine redox modifications, revealing a broad network of redox-sensitive proteins and pathways in skeletal muscle. Recent methodological developments enable quantification of the stoichiometry of reversible oxidative modifications at specific cysteine residues, providing critical insight into the extent and functional relevance of site-specific redox regulation. Redox proteomic approaches are being employed to improve our understanding of the specific redox protein modifications underlying physiological and pathophysiological processes in skeletal muscle. This review summarises current proteomic strategies for quantifying redox post-translational modifications and their application to studying redox signalling in skeletal muscle. Emerging experimental approaches that offer the potential to study the specific roles of site-specific redox modifications in muscle physiology are also discussed. Collectively, these technologies present exciting opportunities to define the mechanistic roles of individual cysteine residues in muscle biology and help uncover new therapeutic avenues for conditions characterised by impaired redox homeostasis.
    Keywords:  mass spectrometry; reactive oxygen species; redox proteomics; skeletal muscle
    DOI:  https://doi.org/10.1113/EP093434
  17. FASEB J. 2026 Nov 30. pii: e72486. [Epub ahead of print]40(22):
      Sarcopenia is an age-related syndrome characterized by progressive declines in muscle mass, strength, and physical performance. To investigate the shared genetic architecture of quantitative traits relevant to sarcopenia, we integrated genome-wide association study (GWAS) summary statistics for appendicular lean mass, hand grip strength, and walking pace from the UK Biobank. Significant genetic correlations among these traits supported multi-trait integration, resulting in an integrated GWAS termed mtMuscleAging. A total of 405 associated loci were identified, including 78 loci with enhanced significance and 33 loci that did not reach genome-wide significance in any individual trait GWAS. Fine-mapping prioritized 538 candidate variants, while integrative post-GWAS analyses identified prioritized genes and highlighted conserved coding regions and biological pathways related to muscle, heart, pancreas, fibroblasts, and aging. Single-cell and single-nucleus transcriptomic analyses further contextualized these genetic findings in aging skeletal muscle and identified alterations in midkine and pleiotrophin signaling and intercellular communication. Phenome-wide association analyses identified genetic relationships between mtMuscleAging and multiple health phenotypes, including cardiovascular disorders. Machine-learning analyses based on prioritized genes captured age-associated skeletal muscle expression patterns, while drug repurposing analyses nominated candidate compounds for further experimental evaluation. Collectively, our findings characterize shared genetic variation across sarcopenia-related traits and provide loci, genes, cellular contexts, and candidate compounds relevant to muscle aging.
    Keywords:  genetic architecture; genome‐wide association studies; multi‐trait integration; muscle aging; sarcopenia
    DOI:  https://doi.org/10.1096/fj.202602625RR
  18. Commun Biol. 2026 Nov 19. pii: 1547. [Epub ahead of print]9(1):
      Exercise is a cornerstone therapy for diabetes because working skeletal muscles take up glucose at dramatically greater rates than postprandial uptake and, notably, do so without a requirement for insulin. Insulin-independent glucose uptake operates normally during exercise and other conditions when adrenergic stimulation inhibits pancreatic insulin release, and it provides a means of glucose disposal in insulin resistant conditions. However, the mechanisms of insulin-independent glucose uptake are not fully understood. Here, we describe a previously unrecognized glucose uptake pathway in muscle, which we refer to as mSGLT based on shared properties with the sodium/glucose cotransporter family (SGLT/Slc5a). In contrast to the abundant muscle GLUT4 transporter, mSGLT activity is not regulated by insulin, requires Na,K-ATPase-α2 activity, and transports the hexose α-methyl-D-glucoside (αMDG), a glucose derivative that is handled by SGLTs but not GLUT4. mSGLT shares antigenicity with the kidney SGLT2 and localizes to the muscle t-tubules together with Na,K-ATPase-α2 and MAP17, the regulatory subunit of SGLT2. Skeletal muscles do not express a full-length transcript of Slc5a2, and mSGLT shows weak affinity for SGLT2-specific inhibitors. mSGLT may be a muscle SGLT isoform. mSGLT and its regulation offer potential muscle-specific targets for treating hyperglycemia and conditions when insulin-stimulated glucose disposal into muscle is impaired.
    DOI:  https://doi.org/10.1038/s42003-026-10848-y
  19. Cell Mol Bioeng. 2026 Oct;19(5): 611-624
       Purpose: Periods of disuse can cause changes to the musculoskeletal system, particularly impacting the composition and strength of skeletal muscle. While many studies have investigated changes in muscle phenotype after unloading, the majority of these studies were performed on animals of a single genetic background or sex. The effect of muscle immobilization on males compared to females, as well as the effect of genetic diversity, is not well understood. The objective of this study was to investigate differential effects of skeletal muscle immobilization in genetically diverse males and females.
    Methods: Diversity Outbred (DO) mice were cast using single limb immobilization (SLI) for three weeks. Total RNA-sequencing was performed on gastrocnemius muscles and analyzed using Ingenuity Pathway Analysis (IPA). Hindlimb muscle morphology and performance were also quantified, using histopathological and functional analyses, respectively.
    Results: Transcriptomic analysis revealed both males and females have downregulated metabolism pathways during unloading. Investigation of matrix modifying pathways revealed differential expression of collagen related pathways, not matrix degradation pathways, in males compared to females. Histopathological analysis of collagen and functional analysis of muscle cross sectional area and volume correlated directly with transcriptomic analysis.
    Conclusion: Together, these findings highlight that despite genetic diversity, immobilization causes similar changes in skeletal muscle metabolism, but differences in extracellular matrix (ECM) remodeling between males and females. This study reveals that sex differences should be considered in designing therapeutics to treat muscle adaptation to immobilization.
    Keywords:  Casting; Gene expression; Genetic diversity; Pathway analysis; Skeletal muscle; Transcriptomics
    DOI:  https://doi.org/10.1007/s12195-026-00942-w
  20. Cell Commun Signal. 2026 Aug 21. pii: 613. [Epub ahead of print]24(1):
      Facioscapulohumeral muscular dystrophy (FSHD) is caused by aberrant expression of the transcription factor DUX4 in skeletal muscle, leading to progressive muscle degeneration and pathological remodelling of the muscle microenvironment. Although the effects of DUX4 in myogenic cells have been extensively investigated, its potential impact on mesenchymal stromal cells (MSCs), which contribute to tissue homeostasis and regeneration, remains poorly understood. Here, we investigated the consequences of ectopic DUX4 expression in human MSCs and assessed their differentiation potential and transcriptional phenotype. DUX4-expressing MSCs acquired selected features of the myogenic phenotype, including expression of muscle-associated markers and formation of myotube-like structures, although their myogenic differentiation and fusion capacity remained markedly lower than those of bona fide myoblasts. In parallel, DUX4 expression substantially altered MSC lineage potential, reducing adipogenic and osteogenic differentiation. Transcriptomic and functional analyses further revealed prominent activation of extracellular matrix (ECM)-associated and pro-fibrotic programmes, together with increased oxidative stress. These findings indicate that DUX4 profoundly alters the differentiation landscape of MSCs, inducing a complex cell state characterised by partial activation of muscle-associated programmes and a prominent pro-fibrotic/ECM-remodelling phenotype. Our results suggest that DUX4 may influence not only myogenic cells but also mesenchymal populations within the FSHD muscle microenvironment. Further studies are required to determine whether these altered MSC states contribute functionally to fibrosis, impaired muscle regeneration or intercellular communication in vivo.
    Keywords:  DUX4; Differentiation; FAP; FSHD; Mesenchymal stromal cells
    DOI:  https://doi.org/10.1186/s12964-026-03162-x
  21. Life Sci Space Res (Amst). 2026 Nov;pii: S2214-5524(26)00060-X. [Epub ahead of print]53 123-137
      Long-duration spaceflight poses multisystemic challenges to human health, exposing astronauts to a complex environment of concurrent stressors, including ionizing radiation, altered circadian rhythms, and weightlessness. Among these, the rapid atrophy of skeletal muscle is a critical barrier to deep-space exploration. While spaceflight is multifactorial, evidence indicates that the mechanical unloading inherent to microgravity is the primary driver of acute muscle protein degradation. Conventional pathological models have primarily focused on the internal mechanisms of muscle fiber atrophy driven directly by this mechanical unloading. However, this perspective cannot fully explain the remarkable speed of muscle atrophy observed during space missions or the limited efficacy of high-intensity, in-orbit physical countermeasures. To address this critical knowledge gap, this review systematically proposes an integrative pathological model centered on the gut-muscle axis. We posit that the microgravity environment does not act solely on the muscle and may also independently induce gut microbiota dysbiosis and compromise gut barrier integrity, leading to metabolic endotoxemia. Critically, we propose a potential synergistic amplification mechanism: an increased load of gut-derived inflammatory signals (lipopolysaccharide, LPS) combines with the independent, mechanical unloading-induced upregulation of the LPS receptor (Toll-like receptor 4, TLR4) in muscle tissue, collectively triggering and amplifying a local inflammatory response. This local muscle inflammation subsequently progresses to systemic inflammation via a cytokine cascade. Ultimately, this process drives rapid muscle breakdown through dual pathological pathways: the activation of protein degradation pathways and the inhibition of protein synthesis via induced anabolic resistance. This novel framework provides a systemic explanation for muscle degradation during spaceflight and a theoretical foundation for developing new countermeasures targeting gut homeostasis, such as precision microbial interventions. Furthermore, the framework has significant translational medicine implications for preventing and treating terrestrial muscle-wasting diseases, including sarcopenia and cachexia.
    Keywords:  Gut microbiota; Gut–muscle axis; Inflammation; Microgravity; Skeletal muscle atrophy
    DOI:  https://doi.org/10.1016/j.lssr.2026.04.006
  22. Free Radic Biol Med. 2026 Nov 17. pii: S0891-5849(26)01280-3. [Epub ahead of print]258 496-509
      Skeletal muscle is a major determinant of whole-body energy expenditure and a prominent site of reactive oxygen species (ROS) production. Rather than acting solely as damaging by-products, ROS and particularly hydrogen peroxide (H2O2) function as spatially and temporally constrained signals that regulate contraction, metabolism, and adaptation to exercise. This review examines how the compartmental organization of skeletal muscle shapes redox signaling and how disruption of this organization contributes to muscle weakness. We discuss peroxiredoxins as peroxide scavengers, sensors, and signal transducers; compare mitochondrial and NADPH oxidase-derived ROS at rest and during contraction; and evaluate current approaches for monitoring ROS and oxidative posttranslational modifications. We then integrate evidence from aging, inflammatory myopathies, Duchenne muscular dystrophy, obesity and type 2 diabetes, rheumatoid arthritis, and cancer cachexia to show how persistent or misplaced oxidant production can impair excitation-contraction coupling, cross-bridge function, glucose uptake, and mitochondrial metabolism. The inconsistent efficacy of general antioxidant interventions likely reflects their limited spatial and temporal specificity and the risk of suppressing physiological redox signals. By contrast, exercise promotes mitochondrial, antioxidant, and anti-inflammatory adaptations across aging and several myopathies, although these benefits depend on sustained participation and support. A clearer definition of source-, compartment-, and target-specific ROS dynamics, combined with improved biosensors and redox-proteomic approaches, will be essential for developing therapies that limit pathological oxidation while preserving adaptive redox signaling in skeletal muscle.
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.11.028
  23. bioRxiv. 2026 Nov 12. pii: 2026.11.06.764992. [Epub ahead of print]
      Loss of skeletal muscle strength and mobility is among the most consequential features of human aging, yet the molecular programs that accompany this decline in women remain poorly understood. Here, we performed deep comprehensive data-independent acquisition (DIA) proteomic profiling of vastus lateralis biopsies from 10 younger (24-30 years) and 10 older (70-84 years) healthy women enrolled through the NIH Common Fund Cellular Senescence Network (SenNet), with matched measurements of grip strength and gait speed. Of 2,391 quantified protein groups, 163 were significantly altered with age, and partial least squares-discriminant analysis completely separated the age groups (cross-validated AUC = 1.00). Older muscle showed increased extracellular matrix and vascular remodeling proteins (TIMP3, COL8A1, ELN, FBN1), nuclear, chromatin and RNA-binding proteins (HMGB1, HMGB2, histone H1.0, MATR3, NCL), and lysosomal and senescence-associated secretory phenotype (SASP)-associated proteins (CTSZ, CTSD, PSAP), together with reduced glycolytic and energetic proteins (GAPDH, ENO3, PHKA1, CYCS). Age effects were robust to adjust for body mass index (BMI). Integrating differential abundance, multivariate importance and participant-level consistency, we defined a 24-protein skeletal muscle aging signature whose score separated all younger from all elderly women. Combining grip strength and gait speed into a combined function score, we found that 23 of the 24 signature proteins correlated with physical function (FDR < 0.05), and the signature score correlated strongly with function (r = -0.79). The senescence-associated alarmins HMGB1 and HMGB2 emerged as lead proteins: HMGB1 showed the strongest association with function (r = -0.86), and both remained associated after adjustment for age group. Together, these data define a senotype proteomic program in aging female skeletal muscle and a molecular signature of muscle function that, after validation, may serve as a readout for interventions that aim to preserve physical performance in elderly women.
    DOI:  https://doi.org/10.64898/2026.11.06.764992
  24. J Muscle Res Cell Motil. 2026 Nov 21. pii: 26. [Epub ahead of print]47(4):
       BACKGROUND: The use of electrical pulse stimulation (EPS) as a method to induce contractions in cultured skeletal muscle has experienced rapid growth in recent years. Despite evidence demonstrating its utility in replicating some acute and chronic adaptations to exercise observed in vivo, there is a lack of evidence concerning the optimal parameters necessary to induce specific molecular adaptations.
    METHODS: This systematic review adhered to the Preferred Reporting Systems for Systematic Reviews. Eligible studies were published in English within peer-reviewed articles. Searches were executed in three databases, with an additional search for grey literature conducted on Google Scholar. Studies investigating chronic EPS in C2C12, and primary human muscle cells were incorporated.
    RESULTS: One hundred and twenty-seven studies spanning over twenty years of research fulfilled the criteria of this review. Outcome measures were categorised into distinct groups: Morphology, gene expression, protein abundance and/or activity, mitochondrial content/function, contractile function, metabolic changes, and cell viability.
    CONCLUSIONS: EPS is effective in inducing a generalised exercise-like response in cultured muscle cells. However, unlike exercise in vivo, the observed molecular responses divergent in endurance/resistance exercises do not occur. Instead, both AKT/mTOR and AMPK/PGC-1α molecular pathways are activated concurrently across a wide range of stimulation durations and intensities. Therefore, EPS in culture is not yet suitable for investigating specific endurance/resistance training adaptations, which may be more readily observed in human and animal models.
    Keywords:   in vitro exercise; Electrical Pulse Stimulation (EPS); Endurance training; Muscle; Resistance training
    DOI:  https://doi.org/10.1007/s10974-026-09744-z
  25. Life Sci Space Res (Amst). 2026 Nov;pii: S2214-5524(26)00055-6. [Epub ahead of print]53 63-72
       BACKGROUND: Simulated microgravity leads to skeletal muscle atrophy, prompting the use of ground-based analogs to investigate molecular adaptations. This study compares transcriptomic responses across six established human and rodent models of muscle disuse.
    METHODS: We analyzed publicly available RNA-seq and microarray datasets from human models including head-down tilt bed rest (HDBR), dry immersion (DI), and unilateral lower limb suspension (ULLS), and rodent models including hindlimb unloading (HU), denervation (DEN), and cast immobilization (CI). Differentially expressed genes (DEGs) were identified using DESeq2 or limma pipelines. Functional enrichment was assessed using gene ontology (GO) over-representation analysis and gene set enrichment analysis (GSEA).
    RESULTS: All models showed distinct but partially overlapping gene signatures, with only 4 to 15 percent shared DEGs. Human comparisons yielded moderate correlation coefficient (R² = 0.37 to 0.67), while human to rodent concordance was minimal (R² <0.25). Despite gene-level variability, core pathways such as muscle tissue development and mitochondrial respiration were consistently enriched. Functional enrichment heatmaps revealed fragmented but directionally consistent biological processes, and several models displayed opposing regulation of shared pathways, especially between HU and HDBR.
    CONCLUSIONS: Ground-based analogs reveal conserved biological programs in muscle disuse, but species-specific and model-specific differences highlight the need for integrative approaches. These findings support the use of multiple models to better understand and counteract microgravity-induced muscle atrophy.
    Keywords:  Disuse-muscle atrophy; Gene expression profiling; Ground-based analogs; Simulated microgravity; Transcriptomics
    DOI:  https://doi.org/10.1016/j.lssr.2026.04.001
  26. Physiol Res. 2026 Nov 20. 75(5): 827-833
      Piezo type mechanosensitive ion channel component 1 (Piezo1) plays a crucial role in skeletal muscle development, regeneration, and myovascular physiological regulation. Piezo1 regulates the assembly of myosin, providing a foundation for skeletal muscle injury repair. Activation of Piezo1 induces proliferation, differentiation, and myotube formation in skeletal muscle satellite cells (MuSCs), while its knockout leads to reduced MuSC numbers, disrupted cell cycle, and abnormal myotube assembly. Additionally, Piezo1 participates in skeletal muscle vascular endothelial cell signaling, inducing nitric oxide (NO) release, regulating vascular smooth muscle tone, increasing skeletal muscle blood flow perfusion, and promoting skeletal muscle injury repair. This paper systematically reviews the structural characteristics, biological mechanisms, and mechanisms of action of Piezo1 in skeletal muscle, providing theoretical basis for the therapeutic application of Piezo1 in skeletal muscle-related diseases. Key words Piezo1 " Skeletal muscle " Muscle satellite cells.
  27. bioRxiv. 2026 Nov 03. pii: 2026.10.30.763089. [Epub ahead of print]
       Background: Sarcopenia is characterized by progressive loss of skeletal muscle mass, strength, and physical function with aging. Motor unit degeneration is a major contributor, but the mechanisms driving age-related deterioration of motor neurons, neuromuscular junctions (NMJs), and muscle fibers remain incompletely understood. Norepinephrine (NE) regulates spinal motor neuron excitability, but its role in motor unit aging has not been established.
    Methods: Whole-cell patch-clamp electrophysiology, optogenetics, fast-scan cyclic voltammetry, microdialysis, high-performance liquid chromatography, western blotting, and chemogenetics were used in mice aged 1-25 months. Motor neuron intrinsic properties were examined in 135 lumbar motor neurons from 81 mice. NE release dynamics, tissue content, and expression of the NE transporter (NET) and α2A-adrenergic autoreceptor were assessed in adult and aged mice. Descending spinally projecting noradrenergic neurons were selectively inhibited in aged mice using a retrograde chemogenetic approach.
    Results: Aging produced progressive motor neuron hyperexcitability characterized by membrane depolarization, increased input resistance, elevated firing frequency, and altered action potential threshold (all P < 0.005). Optogenetically evoked endogenous NE increased motor neuron excitability by reducing action potential latency (P = 0.0001) and decreasing rheobase (P = 0.0028); these effects were prevented by α1-adrenergic receptor blockade (P = 0.0313). Aging enhanced stimulus-evoked spinal NE release, with greater responses at 20 Hz (P = 0.0223), 30 Hz (P = 0.0022), and 40 Hz (P < 0.0001). NE release elicited by stimulation of locus coeruleus and A5 noradrenergic inputs was also increased in aged mice (P = 0.0349 and P = 0.0016, respectively). Basal extracellular NE concentrations were unchanged, whereas spinal cord NE content increased (P = 0.0403). Aging reduced α2A-adrenergic receptor (P = 0.0009) and NET expression (P = 0.0046). Chemogenetic suppression of descending noradrenergic neurons in aged mice increased hindlimb muscle mass (P = 0.0111-0.0344), muscle fiber cross-sectional area (P = 0.0078-0.0467), NMJ innervation (P = 0.0210), and motor neuron soma size (P = 0.0353).
    Conclusions: Aging promotes spinal noradrenergic overdrive characterized by increased NE storage, enhanced activity-dependent NE release, and impaired autoregulatory control. Excessive noradrenergic signaling contributes to motor neuron hyperexcitability and motor unit deterioration. Suppression of descending noradrenergic activity reverses structural features of motor neuron, NMJ, and skeletal muscle aging, identifying spinal noradrenergic signaling as a potential therapeutic target for sarcopenia.
    DOI:  https://doi.org/10.64898/2026.10.30.763089
  28. Exp Physiol. 2026 Nov 15.
      Interval training (INT) of sufficient frequency, intensity and duration can increase biomarkers of skeletal muscle oxidative capacity in humans. Studies typically involve three to four sessions per week; however, the effect of reduced training frequency on this response is unclear. Most studies also do not include a non-exercise control (CON) condition to account for the potential influence of extraneous, uncontrolled factors. We employed a single-leg, counterweighted cycling model to investigate the effect of twice weekly INT for 6 weeks on biomarkers of skeletal muscle oxidative capacity including mitochondrial content and fibre capillarisation. Sixteen healthy active adults (6 males, 10 females; 22 ± 3 years; peak oxygen uptake: 36.1 ± 6.1 mL kg-1 min-1) performed INT with one leg and their contralateral limb served as a CON. INT involved 4 × 5-min bouts at an intensity of 50%-60% Wpeak, interspersed with 2.5 min of recovery at 20% Wpeak. Muscle biopsy samples obtained from the vastus lateralis of both legs before and after the intervention revealed no differences in the primary outcome measure, citrate synthase maximal activity (P = 0.350, time × leg interaction). There were also no differences in multiple markers of mitochondrial protein content or capillarisation (all P > 0.05), except NDUFB8 protein content, which increased post-training in the INT leg only (P = 0.0387). The lack of change in most biomarkers of oxidative capacity may be due to an insufficient training intensity or related to participant fitness or measurement variability as indicated by the typical error of ∼20%-40% between legs as baseline.
    Keywords:  capillaries; interval training; mitochondria; skeletal muscle
    DOI:  https://doi.org/10.1113/EP093493
  29. Free Radic Biol Med. 2026 Nov 18. pii: S0891-5849(26)01288-8. [Epub ahead of print]
      Skeletal muscle atrophy is characterized by a reduction in muscle mass and is associated with oxidative stress, disrupted mitochondrial homeostasis, apoptosis, and cellular senescence. Quercetin (Que) exerts antioxidant and anti-aging biological activities by regulating multiple molecular targets and signaling pathways. Widely utilized in the production of plastics and agrochemical pesticides, trimethyltin chloride (TMT) is a highly toxic substance that poses serious risks to human and animal health. Whether Que can alleviate TMT-induced skeletal muscle atrophy by modulating AMPK signaling remains unclear, and the underlying molecular mechanisms require further investigation. We conducted a systematic exploration of the mechanism underlying TMT-triggered toxicity in skeletal muscle, together with the antagonistic role of Que in attenuating TMT-caused muscle damage. As indicated by the results, oxidative stress, mtROS accumulation, changes in mitophagy-related signaling and disordered mitochondrial dynamics were observed in skeletal muscle upon TMT exposure, accompanied by senescence-associated changes and apoptosis in skeletal muscle cells. In contrast, Que significantly elevated the phosphorylation level of AMPK, partially reversed the TMT-induced changes in PINK1-associated mitophagy signaling, and effectively attenuated the above pathological changes induced by TMT. Taken together, this study suggests that Que alleviates TMT-induced senescence and apoptosis in skeletal muscle potentially via modulation of the p-AMPK-PINK1 signaling axis, and thus confers protection against TMT-induced skeletal muscle atrophy.
    Keywords:  Que; TMT; apoptosis; p-AMPK-PINK1 signaling axis; skeletal muscle atrophy; skeletal muscle senescence
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.11.036
  30. J Muscle Res Cell Motil. 2026 Nov 21. pii: 25. [Epub ahead of print]47(4):
      Preclinical studies indicate that the endocannabinoid system plays an important role in skeletal muscle inflammation, regeneration and metabolism, yet its involvement in human myopathies remains undefined. This study systematically investigated whether endocannabinoid system remodeling occurs in muscle of patients with myopathies. A retrospective meta-analysis was performed using publicly available bulk RNA-sequencing datasets from the Gene Expression Omnibus. In total, 328 muscle biopsies from patients with limb-girdle muscular dystrophy, myotonic dystrophy type 1, facioscapulohumeral muscular dystrophy, inflammatory myopathies, Duchenne/Becker muscular dystrophy, mitochondrial and collagen VI-related myopathy, and 173 control samples were included. Differential expression analyses were conducted per dataset using DESeq2, followed by random-effects meta-analyses for endocannabinoid targets and key endocannabinoid enzymes, with false discovery rate correction. Across disease subtypes, consistent remodeling of the endocannabinoid system was observed. Cannabinoid receptor 1 (CNR1) expression was overall upregulated (log2FC = 0.43, q < 0.001), while fatty acid amide hydrolase (FAAH), the primary enzyme responsible for anandamide and N-acylethanolamine degradation, was consistently downregulated (log2FC = -0.56, q < 0.001). CNR1 exhibited the lowest heterogeneity of all genes analyzed. Enzymes involved in 2-arachidonoylglycerol metabolism displayed disease-specific regulation. Results were robust to sex adjustment and alternative models. This meta-analysis provides the first comprehensive evidence that endocannabinoid signaling is consistently remodeled in human myopathies, across myopathies of different etiology. The downregulation of FAAH and upregulation of CNR1 suggest altered endocannabinoid tone as a shared feature of muscle degeneration. These findings support integrative studies combining longitudinal endocannabinoid and clinical data to understand how endocannabinoid remodeling drives muscle plasticity.
    Keywords:  Cannabinoid receptor; Endocannabinoids; Fatty-acid amide hydrolase; Skeletal muscle degeneration
    DOI:  https://doi.org/10.1007/s10974-026-09743-0
  31. Front Physiol. 2026 ;17 1889632
      Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by loss of muscle strength, reduced muscle quantity or quality, and impaired physical performance. It is associated with adverse outcomes including falls, fractures, physical disability, and mortality, and represents a growing global health concern. However, currently available clinical assessments provide limited information on the electrophysiological and neuromuscular alterations that may precede overt functional decline. Magnetomyography (MMG)-here defined as the non-invasive detection of biomagnetic fields generated by skeletal muscle electrical activity and distinguished from mechanomyography-offers a contactless approach to characterizing muscle electrophysiology. Recent advances in optically pumped magnetometers, portable magnetic shielding, and signal-processing methods have expanded the feasibility of MMG for detecting muscle action potentials, motor-unit activity, fatigue-related changes, and training adaptations. In this perspective review, we summarize the principles and technological development of MMG, critically evaluate current evidence for skeletal muscle assessment, and discuss its potential relevance to sarcopenia. In particular, we propose a conceptual framework in which MMG could complement established assessments by characterizing neuromuscular integrity, investigating potential neural and muscular contributions to functional decline, and monitoring responses to intervention. Importantly, direct evidence in individuals with sarcopenia is currently lacking, and MMG remains an experimental rather than clinically validated diagnostic approach.
    Keywords:  biomagnetism; exercise physiology; magnetomyography; muscle function assessment; neuromuscular ageing; optically pumped magnetometer; sarcopenia; skeletal muscle
    DOI:  https://doi.org/10.3389/fphys.2026.1889632
  32. Res Sq. 2026 Nov 09. pii: rs.3.rs-11516792. [Epub ahead of print]
      Cancer cachexia, defined by involuntary skeletal muscle loss, affects ~ 70% of pancreatic ductal adenocarcinoma (PDAC) patients at diagnosis and independently worsens survival. Here, we identify complement component 1q (C1q) as a driver of PDAC-induced muscle wasting, with coordinated effects across muscle, tumor, and systemic inflammatory compartments. In cachectic PDAC patient muscle, C1q partially co-deposits with IgM, and C1q mRNA correlates with reduced muscle radiation attenuation, a CT-derived measure of muscle quality. In PDAC tumors, C1q protein correlates with immunosuppressive programs and independently predicts poor survival. These findings are recapitulated in orthotopic KPC mice, where C1q mRNA is upregulated in respiratory muscle before cachexia onset, and C1q deposits in tumors and co-deposits with IgM in muscles of cachectic mice. C1qa deletion reduced systemic inflammatory mediators, blocked muscle atrophy, and improved activity and grip strength in KPC mice, while attenuating immune cell infiltration and extracellular matrix remodeling in respiratory muscle. Host C1qa deletion also suppressed angiogenic and immunosuppressive programs in KPC tumors, while increasing intratumoral CD8⁺ T cell density and Granzyme B production. These findings position C1q as a driver of cancer-induced muscle wasting and tumor immunosuppression, supporting C1q inhibition as a potential therapeutic strategy targeting pathological features of poor-prognosis PDAC.
    DOI:  https://doi.org/10.21203/rs.3.rs-11516792/v1
  33. Int J Chron Obstruct Pulmon Dis. 2026 ;21 644331
      Chronic obstructive pulmonary disease (COPD) is a heterogeneous pulmonary disorder characterized by persistent respiratory symptoms and significant extrapulmonary complications. Skeletal muscle dysfunction, a prominent comorbidity, severely compromises exercise capacity and quality of life and independently predicts mortality. While pharmacological therapies effectively control respiratory symptoms, they have limited efficacy against COPD-associated muscle atrophy and functional decline, and the underlying mechanisms remain poorly understood. The RANK/RANKL signaling pathway, a key mediator of muscle-bone crosstalk, is markedly upregulated in COPD and contributes to its musculoskeletal pathology. This review synthesizes current knowledge on the RANK/RANKL pathway in COPD, with a dedicated focus on its mechanistic role in driving skeletal muscle pathology. We emphasize the pathway's role in driving proteolysis via the NF-κB/ubiquitin-proteasome system, impairing myogenic regeneration, sustaining chronic low-grade inflammation, and dysregulating metabolic and calcium homeostasis. These multifaceted pathological effects enable the RANK/RANKL pathway to bridge pulmonary inflammatory injury to peripheral skeletal muscle wasting, thereby representing a plausible therapeutic target to mitigate COPD-related systemic myopathy beyond conventional pulmonary-directed treatments.
    Keywords:  NF-kappa B; RANK/RANKL signaling; chronic obstructive pulmonary disease; muscular atrophy; ubiquitin
    DOI:  https://doi.org/10.2147/COPD.S644331
  34. bioRxiv. 2026 Nov 06. pii: 2026.11.05.764057. [Epub ahead of print]
      Duchenne muscular dystrophy is caused by loss of dystrophin and marked by elevated muscle calcium, usually attributed to contraction-induced membrane damage. Whether calcium rises before muscle can contract, and what sustains it, is unresolved. In Caenorhabditis elegans embryos and patient-derived human myoblasts, dystrophic muscle carries an elevated resting calcium set point before contraction is possible. Embryonic calcium is elevated 400 minutes after fertilization, before movement is detectable or the neuromuscular junction forms. Silencing the plasma membrane calcium pump gene mca-1 raises calcium in wild-type but not dystrophic animals, whereas silencing its paralogue raises it in both: the limitation is specific to that export route. Dystrophic human myoblasts have less pump; pump inhibition or silencing increases calcium preferentially in healthy cells and raising pump expression lowers calcium most in dystrophic cells. Constrained calcium export is an early, continuing determinant of the dystrophic set point.
    DOI:  https://doi.org/10.64898/2026.11.05.764057
  35. Sci Adv. 2026 Nov 20. 12(47): eaej1043
      Facioscapulohumeral muscular dystrophy (FSHD) is a leading neuromuscular disorder caused by the aberrant expression of the transcription factor double homeobox 4 (DUX4) in skeletal muscle. While DUX4 is normally restricted to early embryonic development, its reactivation in FSHD triggers chronic inflammation and progressive muscle degeneration. However, the precise molecular links between DUX4 and persistent immune activation remain poorly understood. Here, we show that DUX4 induces a viral mimicry-like pathway that is fundamentally uncoupled from canonical type I interferon (IFN) activation. Instead, DUX4 establishes a non-canonical innate immune state dominated by IFN-γ signaling, providing a mechanistic explanation for the non-resolving inflammation characteristic of the disease. We demonstrate that while IFN-γ treatment alone is sufficient to recapitulate key DUX4 pathogenic effects, its inhibition rescues muscle inflammation and halts disease progression in FSHD models. These findings define a "skewed viral mimicry" process driven by a disease-specific transcription factor and identify IFN-γ as a primary therapeutic target for tissue-informed immunomodulation in muscular dystrophy.
    DOI:  https://doi.org/10.1126/sciadv.aej1043
  36. Geroscience. 2026 Nov 16.
      Sarcopenia is a progressive, age-related skeletal muscle disorder characterised by reduced muscle strength, accompanied by loss of muscle mass and impaired muscle function. Growing interest in nutrition in older adults has also increased attention to nucleotides as potentially relevant dietary components that may participate in muscle regeneration, energy metabolism, and cellular responses to stress. The aim of this review was to critically evaluate evidence on conventional dietary nucleotides, nucleoproteins, and compounds related to NAD+ metabolism in the context of muscle ageing and sarcopenia. A structured literature review was conducted, with study identification and selection carried out in accordance with selected elements of PRISMA 2020. A total of 3090 records were identified in PubMed/MEDLINE, Scopus, and the Web of Science Core Collection. After removal of 1327 duplicates, 1763 unique records were screened. Of 159 publications assessed in full text, 62 were retained. Three additional clinical reports identified during revision brought the qualitative synthesis to 65 publications. The most direct evidence for conventional nucleotides comes from cellular and animal models and from several human intervention studies. These findings indicate the potential to attenuate atrophy, support myogenesis, and improve selected functional outcomes. Evidence on NAD+  precursors is considerably more extensive, but the clinical findings are heterogeneous. Nucleotides remain a promising but experimental nutritional strategy. Current evidence does not justify considering mixtures of AMP, CMP, GMP, and UMP, nucleoproteins, NMN, and NR as equivalent interventions or recommending their routine use in the treatment of sarcopenia.
    Keywords:  Dietary nucleotides; Muscle atrophy; NAD+  metabolism; Nutritional supplementation; Older adults; Sarcopenia; Skeletal muscle
    DOI:  https://doi.org/10.1007/s11357-026-02659-0
  37. Nat Commun. 2026 Nov 20. pii: 11676. [Epub ahead of print]17(1):
    DBDS Genomic Consortium
      Muscle mass is central to physical function and metabolic health, but can decrease with disease, aging and weight loss interventions. As weight loss interventions become more widely used, agents that preserve or increase muscle mass are needed. To identify such therapeutic opportunities, we perform genome-wide association meta-analyses of arm, leg, trunk and total lean mass measured by dual-energy X-ray absorptiometry, a widely used method to estimate muscle mass. We identify 63 loci, including a rare missense variant in MSTN (p.Ile225Thr, rs143242500), which has the largest effect on leg lean mass (β = 0.28 SD [95% CI: 0.19, 0.37], P = 1.9 × 10-9). MSTN encodes myostatin, a negative regulator of skeletal muscle mass and a therapeutic target for muscle wasting disorders. Here, we identify a genome-wide significant association at MSTN in humans and characterize its functional consequences, providing genetic evidence that may inform the long-term systemic effects of myostatin inhibition.
    DOI:  https://doi.org/10.1038/s41467-026-77766-9